In vivo Magnetic Resonance Imaging of Atherosclerotic Lesions with a Newly Developed Evans Blue-DTPA-Gadolinium Contrast Medium in Apolipoprotein-E-Deficient Mice

  • Yasuda, Satoshi
  • Ikuta, Kenjiro
  • Uwatoku, Toyokazu
  • Oi, Keiji
  • Abe, Kohtaro
  • Hyodo, Fuminori
  • Yoshimitsu, Kengo
  • Sugimura, Kohtaro
  • Utsumi, Hideo
  • Katayama, Yoshiki
  • Shimokawa, Hiroaki
Journal of Vascular Research 45(2):p 123-128, February 2008.

Background

Magnetic resonance imaging (MRI) contrast agents that specifically detect atherosclerotic plaque may be useful for the noninvasive detection of the plaque. We have recently developed a new contrast agent, Evans blue-DTPA-gadolinium (EB-DTPA-Gd), which selectively accumulates vascular lesions with endothelial removal. In this study, we examined whether EB-DTPA-Gd is also useful for in vivo imaging of atherosclerotic plaques.

Methods

We used male apolipoprotein-E-deficient (ApoE–/–) mice of different ages (3, 6 and 12 months old) and age-matched male wild-type mice. After a single intravenous administration of EB-DTPA-Gd (160 μM/kg body weight), MRI T1 signal was obtained in vivo.

Results

Increased signal intensity in the aortic wall was noted within 10–20 min after intravenous injection of EB-DTPA-Gd and was maintained for 30 min. The MRI enhancement in the aorta of ApoE–/– mice was increased in accordance with age, whereas no such enhancement was noted in wild-type mice. Histological examination demonstrated that there was a topological correlation between the site of MRI enhancement and that of atherosclerotic plaque.

Conclusions

These results indicate that EB-DTPA-Gd is a useful MRI contrast medium for the in vivo detection of atherosclerotic plaques.

Copyright © 2008 S. Karger AG, Basel